Developer docs
API playgroundTry for free, no card

Search company profiles

merck vaccines

Full company profile

uuid02m8eew

Namestring
merck vaccines
Legal namestring
Merck & Co., Inc.
Company typeenum
Public
Founded yearint
1891
Descriptiontext

Merck Vaccines is the vaccines division of Merck & Co., Inc. (NYSE: MRK), a US-headquartered pharmaceutical company founded in 1891 and based in Rahway, New Jersey. The division operates MerckVaccines.com, a dedicated portal serving US healthcare professionals with product information, ordering functionality, and clinical resources. Its US portfolio comprises 15 vaccines addressing pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), rotavirus, and Ebola. Underlying technology spans four vaccine platforms: recombinant (e.g., GARDASIL), live attenuated (e.g., M-M-R II, VARIVAX), conjugate (e.g., CAPVAXIVE, VAXNEUVANCE), and inactivated, plus newer biologic modalities such as the RSV monoclonal antibody ENFLONSIA. Distribution runs through a direct-ordering platform and prime distributor partners, with select co-marketing arrangements (notably VAXELIS with Sanofi via the MSP Vaccine Company joint venture) and CDC alignment on US immunization schedules. Pricing is not publicly disclosed at the product level, and revenue and headcount are not reported at the division level, falling within Merck's consolidated pharmaceuticals segment reporting.

Short descriptiontext

Merck Vaccines is the vaccines division of Merck & Co., Inc., distributing 15 FDA-approved vaccines to US healthcare professionals through a dedicated direct-ordering portal at MerckVaccines.com.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNorth Wales, United States
HQ citystring
North Wales
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
human vaccines, pediatric immunization, pneumococcal vaccines, HPV vaccination, monoclonal antibodies
Industry3 codes
PRIMARYHLAAAEAA
Prophylactic Human Vaccines (routine, pediatric, adult)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAJAHAF
Vaccine Ordering, Inventory Management & Cold-Chain Logistics
Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration
SECONDARYHLAIAEAB
Adult Vaccines
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Human Vaccines
No data
GTM motion1 record

Each record includes

Type, Description, Source

Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Merck Connect
Description

Practical and patient-centered resources for health care professionals.

merckvaccines.com
+3 more records
Core offering1 text field

Merck Vaccines develops, manufactures, and distributes a portfolio of 15 FDA-approved human vaccines and one monoclonal antibody for the US market, sold to healthcare professionals through a dedicated direct-ordering portal. The portfolio spans pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A and B, Haemophilus influenzae type b, rotavirus, tuberculosis, Ebola, and RSV prevention.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Merck Vaccines is a comprehensive vaccine portfolio company offering 15 distinct vaccine products for healthcare professionals in the United States. The portfolio includes pediatric combination vaccines (VAXELIS hexavalent, ProQuad MMRV, M-M-R II), standalone pediatric vaccines (PedvaxHIB, RotaTeq, VARIVAX, RECOMBIVAX HB, VAQTA), adult/pneumococcal vaccines (CAPVAXIVE 21-valent, VAXNEUVANCE 15-valent, PNEUMOVAX 23), HPV prevention (GARDASIL 9), travel/epidemic vaccines (BCG, ERVEBO Ebola), and monoclonal antibody products (ENFLONSIA for RSV). The company operates MerckVaccines.com as a B2B ordering and information portal for healthcare providers, with sister sites for patient resources (Merck Connect), account management (My Merck Accounts), access support (Merck Access Program), and patient assistance (MerckHelps).

Product and service15 records
1CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine)
CategoryVaccine
Description

Pneumococcal 21-valent conjugate vaccine for protection against pneumococcal disease in adults, administered by healthcare professionals.

2GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant)
CategoryVaccine
Description

9-valent recombinant HPV vaccine for prevention of HPV-related cancers and diseases, administered to pediatric and adult patients by healthcare professionals.

3VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine)
CategoryVaccine
Description

Pneumococcal 15-valent conjugate vaccine for pediatric and adult pneumococcal protection, administered by healthcare professionals.

4ENFLONSIA (clesrovimab-cfor) 105 mg injection
CategoryMonoclonal Antibody
Description

Monoclonal antibody injection for respiratory syncytial virus (RSV) prevention, administered by healthcare professionals.

5ERVEBO (Ebola Zaire Vaccine, Live)
CategoryVaccine
Description

Live attenuated vaccine for Ebola Zaire virus, administered by healthcare professionals for epidemic preparedness.

6M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live)
CategoryVaccine
Description

Live attenuated combined vaccine for measles, mumps, and rubella immunization, administered by healthcare professionals.

7ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live)
CategoryVaccine
Description

Combined live attenuated vaccine for measles, mumps, rubella, and varicella (chickenpox), administered to pediatric patients by healthcare professionals.

8PedvaxHIB (Haemophilus b Conjugate Vaccine, Meningococcal Protein Conjugate)
CategoryVaccine
Description

Haemophilus influenzae type b (Hib) conjugate vaccine using meningococcal protein conjugate technology for pediatric immunization.

9PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent)
CategoryVaccine
Description

23-valent pneumococcal vaccine for broad pneumococcal protection in adults, administered by healthcare professionals.

10RECOMBIVAX HB (Hepatitis B Vaccine, Recombinant)
CategoryVaccine
Description

Recombinant hepatitis B vaccine for hepatitis B prevention, administered to pediatric and adult patients by healthcare professionals.

11RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent)
CategoryVaccine
Description

Oral live pentavalent rotavirus vaccine for rotavirus gastroenteritis prevention in infants, administered by healthcare professionals.

12VAQTA (Hepatitis A Vaccine, Inactivated)
CategoryVaccine
Description

Inactivated hepatitis A vaccine for hepatitis A prevention, administered to pediatric and adult patients by healthcare professionals.

13VARIVAX (Varicella Virus Vaccine Live)
CategoryVaccine
Description

Live attenuated varicella (chickenpox) vaccine for pediatric immunization, administered by healthcare professionals.

14VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine)
CategoryVaccine
Description

Hexavalent combination vaccine covering diphtheria, tetanus, pertussis, poliovirus, Haemophilus b, and hepatitis B for pediatric immunization; a trademark of MSP Vaccine Company distributed by Merck and Sanofi.

15BCG Vaccine U.S.P.
CategoryVaccine
Description

Bacillus Calmette-Guérin (BCG) live attenuated vaccine for tuberculosis immunization, administered by healthcare professionals.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is distributed by Merck and Sanofi for MSP Vaccine Company. VAXELIS is a trademark of MSP Vaccine Company.

Strategic tierCoreTypeOthers
Description

MerckVaccines.com links to CDC resources including immunization schedules, Vaccines for Children program, and travelers health information for healthcare professionals.

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major Big Pharma competitor with the leading PCV franchise (Prevnar/Prevnar 20), HPV vaccine, and COVID-19 vaccine (Comirnaty) via BioNTech. Directly competes with Merck Vaccines across multiple respiratory and pediatric categories and operates a similar large-pharma distribution model to US healthcare professionals.

TypeBroad incumbent
Description

Global vaccine leader (Shingrix, Bexsero, Cervarix historically, hepatitis, flu) competing head-to-head with Merck in shingles, HPV, and pediatric combination vaccines, with strong ex-US reach that contrasts with Merck Vaccines' US-only portal.

TypeDirect peer
Description

Sanofi Pasteur is one of the world's largest vaccine franchises (flu, pediatric combinations, travel, RSV via nirsevimab/Beyfortus) and a direct co-marketing partner with Merck on VAXELIS, making it both ally and competitor across multiple categories.

TypeEmerging player
Description

mRNA platform company with approved COVID vaccine (Spikevax) and pipeline programs in RSV, flu, and pneumococcal disease that overlap directly with Merck Vaccines' franchises, representing a technology-driven competitive threat.

TypeDirect peer
Description

Global influenza vaccine leader and broader specialty vaccines player (cell-based flu, pandemic preparedness) competing directly with Merck Vaccines in adult respiratory and public-health immunization channels.

TypeDirect peer
Description

Specialty vaccines and biologics company with travel/anthrax/smallpox portfolio, overlapping with Merck Vaccines in travel and select specialty indications and competing for similar US public-health and HCP channels.

TypeEmerging player
Description

Specialty vaccine company focused on smallpox/mpox (JYNNEOS) and travel/endemic disease vaccines, competing with Merck Vaccines in travel and bioterrorism/public-health preparedness segments.

TypeEmerging player
Description

Vaccine adjuvants and hepatitis B vaccine (Heplisav-B) company competing with Merck Vaccines' RECOMBIVAX HB in the US adult hepatitis B market with a differentiated CpG adjuvant platform.

TypeEmerging player
Description

Protein-based vaccine developer with an approved COVID vaccine and pipeline programs in flu and RSV, using a recombinant nanoparticle platform that competes with Merck's traditional and mRNA-adjacent approaches.

TypeEmerging player
Description

mRNA technology company partnering with Pfizer on Comirnaty and pursuing mRNA-based flu and other vaccines, representing a pipeline competitor to Merck Vaccines' respiratory and infectious disease franchises.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

merck vaccines

Human Vaccinesmerckvaccines.com

Merck Vaccines is the vaccines division of Merck & Co., Inc., distributing 15 FDA-approved vaccines to US healthcare professionals through a dedicated direct-ordering portal at MerckVaccines.com.

What merck vaccines does

Merck Vaccines is the vaccines division of Merck & Co., Inc. (NYSE: MRK), a US-headquartered pharmaceutical company founded in 1891 and based in Rahway, New Jersey. The division operates MerckVaccines.com, a dedicated portal serving US healthcare professionals with product information, ordering functionality, and clinical resources. Its US portfolio comprises 15 vaccines addressing pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), rotavirus, and Ebola. Underlying technology spans four vaccine platforms: recombinant (e.g., GARDASIL), live attenuated (e.g., M-M-R II, VARIVAX), conjugate (e.g., CAPVAXIVE, VAXNEUVANCE), and inactivated, plus newer biologic modalities such as the RSV monoclonal antibody ENFLONSIA. Distribution runs through a direct-ordering platform and prime distributor partners, with select co-marketing arrangements (notably VAXELIS with Sanofi via the MSP Vaccine Company joint venture) and CDC alignment on US immunization schedules. Pricing is not publicly disclosed at the product level, and revenue and headcount are not reported at the division level, falling within Merck's consolidated pharmaceuticals segment reporting.

merck vaccines firmographics

Firmographics
Name
merck vaccines
Legal name
Merck & Co., Inc.
Website
https://merckvaccines.com
Company type
Public
Founded year
1891
Operating status
Operating
Short description
Merck Vaccines is the vaccines division of Merck & Co., Inc., distributing 15 FDA-approved vaccines to US healthcare professionals through a dedicated direct-ordering portal at MerckVaccines.com.
Ownership category
akta.pro rank

merck vaccines industry classification

Industry
Product category
Human Vaccines
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAEAA
Prophylactic Human Vaccines (routine, pediatric, adult)
Healthcare & Life Sciences/Biotechnology & Biologics/Vaccines & Immunization Biologics
SECONDARYHLAJAHAF
Vaccine Ordering, Inventory Management & Cold-Chain Logistics
Healthcare & Life Sciences/Public Health, Government & Regulators/Immunization Programs & Vaccine Administration
SECONDARYHLAIAEAB
Adult Vaccines

Keywords

  • Human vaccines
  • Pediatric immunization
  • Pneumococcal vaccines
  • HPV vaccination
  • Monoclonal antibodies

Where merck vaccines is headquartered

Location

Headquarters

HQ city
North Wales
HQ country
United States
HQ region
North America

Offices1 record

Markets served

merck vaccines business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure, Personnel

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

merck vaccines product offering

Product offering

Core offering

Merck Vaccines develops, manufactures, and distributes a portfolio of 15 FDA-approved human vaccines and one monoclonal antibody for the US market, sold to healthcare professionals through a dedicated direct-ordering portal. The portfolio spans pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A and B, Haemophilus influenzae type b, rotavirus, tuberculosis, Ebola, and RSV prevention.

Product overview

Merck Vaccines is a comprehensive vaccine portfolio company offering 15 distinct vaccine products for healthcare professionals in the United States. The portfolio includes pediatric combination vaccines (VAXELIS hexavalent, ProQuad MMRV, M-M-R II), standalone pediatric vaccines (PedvaxHIB, RotaTeq, VARIVAX, RECOMBIVAX HB, VAQTA), adult/pneumococcal vaccines (CAPVAXIVE 21-valent, VAXNEUVANCE 15-valent, PNEUMOVAX 23), HPV prevention (GARDASIL 9), travel/epidemic vaccines (BCG, ERVEBO Ebola), and monoclonal antibody products (ENFLONSIA for RSV). The company operates MerckVaccines.com as a B2B ordering and information portal for healthcare providers, with sister sites for patient resources (Merck Connect), account management (My Merck Accounts), access support (Merck Access Program), and patient assistance (MerckHelps).

Differentiator

Problem solved

Functional benefit

Brands

  • Merck Connect: Practical and patient-centered resources for health care professionals.
  • My Merck Accounts
  • Merck Access Program
  • MerckHelps

Products and services

  • CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) Pneumococcal 21-valent conjugate vaccine for protection against pneumococcal disease in adults, administered by healthcare professionals.
  • GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) 9-valent recombinant HPV vaccine for prevention of HPV-related cancers and diseases, administered to pediatric and adult patients by healthcare professionals.
  • VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) Pneumococcal 15-valent conjugate vaccine for pediatric and adult pneumococcal protection, administered by healthcare professionals.
  • ENFLONSIA (clesrovimab-cfor) 105 mg injection Monoclonal antibody injection for respiratory syncytial virus (RSV) prevention, administered by healthcare professionals.
  • ERVEBO (Ebola Zaire Vaccine, Live) Live attenuated vaccine for Ebola Zaire virus, administered by healthcare professionals for epidemic preparedness.
  • M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) Live attenuated combined vaccine for measles, mumps, and rubella immunization, administered by healthcare professionals.
  • ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Combined live attenuated vaccine for measles, mumps, rubella, and varicella (chickenpox), administered to pediatric patients by healthcare professionals.
  • PedvaxHIB (Haemophilus b Conjugate Vaccine, Meningococcal Protein Conjugate) Haemophilus influenzae type b (Hib) conjugate vaccine using meningococcal protein conjugate technology for pediatric immunization.
  • PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent) 23-valent pneumococcal vaccine for broad pneumococcal protection in adults, administered by healthcare professionals.
  • RECOMBIVAX HB (Hepatitis B Vaccine, Recombinant) Recombinant hepatitis B vaccine for hepatitis B prevention, administered to pediatric and adult patients by healthcare professionals.
  • RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) Oral live pentavalent rotavirus vaccine for rotavirus gastroenteritis prevention in infants, administered by healthcare professionals.
  • VAQTA (Hepatitis A Vaccine, Inactivated) Inactivated hepatitis A vaccine for hepatitis A prevention, administered to pediatric and adult patients by healthcare professionals.
  • VARIVAX (Varicella Virus Vaccine Live) Live attenuated varicella (chickenpox) vaccine for pediatric immunization, administered by healthcare professionals.
  • VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Hexavalent combination vaccine covering diphtheria, tetanus, pertussis, poliovirus, Haemophilus b, and hepatitis B for pediatric immunization; a trademark of MSP Vaccine Company distributed by Merck and Sanofi.
  • BCG Vaccine U.S.P. Bacillus Calmette-Guérin (BCG) live attenuated vaccine for tuberculosis immunization, administered by healthcare professionals.

Companies that use merck vaccines

Customer profile

Segments2 records

Ideal customer profiles2 records

merck vaccines technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

merck vaccines partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • SanoficoreChannel Partner/ Reseller/ DistributorVAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is distributed by Merck and Sanofi for MSP Vaccine Company. VAXELIS is a trademark of MSP Vaccine Company.
  • CDC (Centers for Disease Control and Prevention)coreOthersMerckVaccines.com links to CDC resources including immunization schedules, Vaccines for Children program, and travelers health information for healthcare professionals.

Scale indicators2 records

Expansion highlights5 records

merck vaccines competitors and assessment

Company assessment

Broad incumbents

  • Pfizer: Major Big Pharma competitor with the leading PCV franchise (Prevnar/Prevnar 20), HPV vaccine, and COVID-19 vaccine (Comirnaty) via BioNTech. Directly competes with Merck Vaccines across multiple respiratory and pediatric categories and operates a similar large-pharma distribution model to US healthcare professionals.
  • GSK: Global vaccine leader (Shingrix, Bexsero, Cervarix historically, hepatitis, flu) competing head-to-head with Merck in shingles, HPV, and pediatric combination vaccines, with strong ex-US reach that contrasts with Merck Vaccines' US-only portal.

Direct peers

  • Sanofi: Sanofi Pasteur is one of the world's largest vaccine franchises (flu, pediatric combinations, travel, RSV via nirsevimab/Beyfortus) and a direct co-marketing partner with Merck on VAXELIS, making it both ally and competitor across multiple categories.
  • CSL Seqirus: Global influenza vaccine leader and broader specialty vaccines player (cell-based flu, pandemic preparedness) competing directly with Merck Vaccines in adult respiratory and public-health immunization channels.
  • Emergent BioSolutions: Specialty vaccines and biologics company with travel/anthrax/smallpox portfolio, overlapping with Merck Vaccines in travel and select specialty indications and competing for similar US public-health and HCP channels.

Emerging players

  • Moderna: mRNA platform company with approved COVID vaccine (Spikevax) and pipeline programs in RSV, flu, and pneumococcal disease that overlap directly with Merck Vaccines' franchises, representing a technology-driven competitive threat.
  • Bavarian Nordic: Specialty vaccine company focused on smallpox/mpox (JYNNEOS) and travel/endemic disease vaccines, competing with Merck Vaccines in travel and bioterrorism/public-health preparedness segments.
  • Dynavax Technologies: Vaccine adjuvants and hepatitis B vaccine (Heplisav-B) company competing with Merck Vaccines' RECOMBIVAX HB in the US adult hepatitis B market with a differentiated CpG adjuvant platform.
  • Novavax: Protein-based vaccine developer with an approved COVID vaccine and pipeline programs in flu and RSV, using a recombinant nanoparticle platform that competes with Merck's traditional and mRNA-adjacent approaches.
  • BioNTech: mRNA technology company partnering with Pfizer on Comirnaty and pursuing mRNA-based flu and other vaccines, representing a pipeline competitor to Merck Vaccines' respiratory and infectious disease franchises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

merck vaccines financial estimates

Financial estimate

Revenue estimate

Valuation estimate

merck vaccines leadership team

Management profile

Number of profiles

merck vaccines funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

merck vaccines M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about merck vaccines

What does merck vaccines do?

Merck Vaccines develops, manufactures, and distributes a portfolio of 15 FDA-approved human vaccines and one monoclonal antibody for the US market, sold to healthcare professionals through a dedicated direct-ordering portal. The portfolio spans pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A and B, Haemophilus influenzae type b, rotavirus, tuberculosis, Ebola, and RSV prevention.

Is merck vaccines a public or private company?

merck vaccines is a public company. It is classified as public and is currently operating.

When was merck vaccines founded?

merck vaccines was founded in 1891.

Where is merck vaccines based?

merck vaccines is headquartered in North Wales, United States, in the North America region.

Who are merck vaccines's main competitors?

Broad incumbents on record are Pfizer and GSK. Direct peers are Sanofi, CSL Seqirus and Emergent BioSolutions. Emerging players are Moderna, Bavarian Nordic, Dynavax Technologies, Novavax and BioNTech.

Does merck vaccines have an API?

No public API is recorded for merck vaccines.

What industry is merck vaccines in?

merck vaccines's product category is Human Vaccines. Its primary akta.pro industry code is HLAAAEAA, Prophylactic Human Vaccines (routine, pediatric, adult), with a secondary code of HLAJAHAF, Vaccine Ordering, Inventory Management & Cold-Chain Logistics. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales